Oxford Immunotec (OXFD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 12-2011 | |
| Sales | 7,679 | 0 | 5,821 | 4,911 | 0 |
| Cost of Goods | 4,367 | N/A | 3,387 | 3,008 | N/A |
| Gross Profit | 3,312 | N/A | 2,434 | 1,903 | N/A |
| Operating Expenses | 5,974 | 0 | 6,098 | 4,590 | 0 |
| Operating Income | -2,295 | N/A | -3,277 | -2,679 | N/A |
| Interest Expense | 39 | 0 | 0 | 0 | 0 |
| Other Income | 1,143 | 0 | -346 | -1,349 | 0 |
| Pre-tax Income | -1,191 | 0 | -3,623 | -4,028 | 0 |
| Income Tax | 10 | N/A | 10 | 6 | N/A |
| Net Income Continuous | -1,201 | N/A | -3,633 | -4,034 | N/A |
| Net Income | $-1,201 | $N/A | $-3,633 | $-4,034 | $N/A |
| EPS Basic Total Ops | -0.56 | N/A | -0.27 | -0.41 | N/A |
| EPS Basic Continuous Ops | -0.56 | N/A | -0.27 | -0.41 | N/A |
| EPS Diluted Total Ops | -0.56 | N/A | -0.27 | -0.41 | N/A |
| EPS Diluted Continuous Ops | -0.56 | N/A | -0.27 | -0.41 | N/A |
| EBITDA(a) | $-2,000 | $N/A | $-3,074 | $-2,679 | $N/A |